477
There is still a lot of confusion on the CoronaVac, the Chinese vaccine produced by Sinovac. The WHO has approved its emergency use, calling it “safe, effective and of guaranteed quality after two doses” while the EMA has announced the “rolling review”, ie a continuous review to obtain “sufficient evidence for one application formal marketing authorization in Europe “. Now the magazine Lancet publishes the latest study conducted by researchers from Hebei Provincial Center for Disease Control and the manufacturing company, announcing safety and a strong antibody response in children and adolescents.
.